Todd C. Lee MD MPH FIDSA
Todd C. Lee MD MPH FIDSA
Explore linked clinical trials.4 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Clopidogrel vs. Aspirin for Cardiovascular Risk Reduction in Patients With S. Aureus Bacteremia | Staphylococcus Aureus Bloodstream Infection; Staphylococcus Aureus Endocarditis; Staphylococcus Aureus Septicemia | Recruiting | Phase 4 | 2026-09-24 | NCT06650488 | |
| Combination Cefazolin With Ertapenem for Methicillin-susceptible Staphylococcus Aureus Bacteremia | Bacterial Infections and Mycoses, Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Systemic Inflammatory Response Syndrome, bacterial infectious disease, bacterial infectious disease with sepsis, gram-positive bacterial infections, staphylococcal infection | Recruiting | Phase 2 | 2026-09-11 | NCT04886284 | |
| Daptomycin vs. Vancomycin for the Treatment of Methicillin Resistant S. Aureus Bacteremia | S. Aureus Bacteremia; S. Aureus Bloodstream Infection; Staphylococcus Aureus Bacteremia; Staphylococcus Aureus Endocarditis; Staphylococcus Aureus Septicemia | Recruiting | Phase 4 | 2026-09-09 | NCT06637332 | |
| Low Dose Trimethoprim-Sulfamethoxazole for the Treatment of Pneumocystis Jirovecii Pneumonia | Bacterial Infections and Mycoses, Infections, Pneumocystis infectious disease, Pneumocystis jirovecii Infection, fungal infectious disease, fungal lung infectious disease, lung disorder, pneumocystosis, pneumonia, respiratory system disorder, respiratory tract infectious disorder | Recruiting | Phase 3 | 2026-02-20 | NCT04851015 |